BELITE BIO, INC(BLTE)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BLTE Stock Analysis & AI Quality Score
AI stock analysis and institutional research for BELITE BIO, INC (BLTE), a Healthcare sector company. BLTE is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (FY 2025), BELITE BIO, INC reports net income of $-77.6M, free cash flow of $-37.1M. Top institutional holders of BLTE by reported 13-F value include Darwin Global Management, Ltd., Paradigm Biocapital Advisors, UBS Group AG, based on the most recent SEC filings. BLTE trades on the Nasdaq exchange and files with the SEC under CIK 1889109. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BLTE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for BELITE BIO, INC directly from SEC EDGAR.
Net Income
FY 2025
$-77.6M
Free Cash Flow
FY 2025
$-37.1M
Get alerted when BLTE's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for BELITE BIO, INC including:
Top Institutional Holders of BLTE
Darwin Global Management, Ltd.
$456.1M3,057,412 shParadigm Biocapital Advisors LP
$177.7M1,114,784 shUBS Group AG
$122.5M768,359 shRTW INVESTMENTS, LP
$114.1M715,332 shMILLENNIUM MANAGEMENT LLC
$90.9M570,088 shHolocene Advisors, LP
$78.8M494,495 shEVENTIDE ASSET MANAGEMENT, LLC
$57.0M357,650 shDEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
$48.5M304,013 shMORGAN STANLEY
$32.1M201,409 shPERCEPTIVE ADVISORS LLC
$24.2M151,979 sh
| Fund | Value | Shares |
|---|---|---|
| Darwin Global Management, Ltd. | $456.1M | 3,057,412 |
| Paradigm Biocapital Advisors LP | $177.7M | 1,114,784 |
| UBS Group AG | $122.5M | 768,359 |
| RTW INVESTMENTS, LP | $114.1M | 715,332 |
| MILLENNIUM MANAGEMENT LLC | $90.9M | 570,088 |
| Holocene Advisors, LP | $78.8M | 494,495 |
| EVENTIDE ASSET MANAGEMENT, LLC | $57.0M | 357,650 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | $48.5M | 304,013 |
| MORGAN STANLEY | $32.1M | 201,409 |
| PERCEPTIVE ADVISORS LLC | $24.2M | 151,979 |
More Healthcare Companies
View all Healthcare →Put BLTE on your watchlist
Track score changes the day BELITE BIO, INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BLTE a good stock to buy?
13F Pro's AI-powered analysis of BELITE BIO, INC (BLTE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BLTE are available on the BLTE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own BLTE?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BLTE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of BELITE BIO, INC's investment landscape.